| 樹德科技大學 |
2009 |
AStudyonUsingpublicRelationtoBuildandDevelopBrand.BytheExampleofTrungNguyenCoffeeasaCaseStudy
|
張妙秋; Truong Dieu Thu |
| 樹德科技大學 |
2010 |
AStudyonVanityTrait,BrandImageandSelf-ConceptAffectingPurchasingBehaviorofConsumer:ACaseofCosmeticProducts
|
陳明草; Tran Minh Thao |
| 國立臺灣大學 |
2015 |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun; Kao, Jia-Horng; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun;Kao, Jia-Horng; JIA-HORNG KAO; Yang, Sheng-Shun; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-09-04T06:11:35Z |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang S.-S.; JIA-HORNG KAO |
| 國立彰化師範大學 |
2007-05 |
ASUOI系統觀察工具教練訓練行為之文獻探討
|
吳聲豪; 王宗進 |
| 國立政治大學 |
2009 |
Asus Mini EMBA 產學合作專案訓練
|
別蓮蒂 |
| 元智大學 |
Jun-15 |
ASUS PORTABLE AIO"PUPPY LOVE"
|
Shih Ming Chang |
| 元智大學 |
Aug-14 |
ASUS Portable AIO廣告「流浪狗篇」
|
Shih Ming Chang |
| 元智大學 |
Sep-16 |
ASUS Zenbo 中秋團圓篇廣告
|
Shih Ming Chang |
| 元智大學 |
Dec-16 |
ASUS Zenbo 作伙篇廣告
|
Shih Ming Chang |
| 國立政治大學 |
2011-11 |
Aśvaghoṣa and the Transformation of Buddhism
|
黃柏棋 |
| 臺大學術典藏 |
2020-10-20T01:45:40Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; TAI-CHUNG HUANG; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; TIEN FENG-MING; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2020-10-12 |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; Tien, Hwei-Fang; Tang, Jih-Luh; Lin, Chien-Chin; Lee, Sze-Hwei; Tsai, Cheng-Hong; Wu, Shan-Ju; Hou, Hsin-An; Huang, Tai-Chung; Kuo, Yuan-Yeh; MING YAO; Chang, Koping; Lin, Chung-Wu; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien |
| 臺大學術典藏 |
2020-10-28T02:42:55Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; JIH-LUH TANG; Lee, Sze-Hwei; CHENG-HONG TSAI; Wu, Shan-Ju; HSIN-AN HOU; TAI-CHUNG HUANG; YUAN-YEH KUO; MING YAO; Chang, Koping; CHUNG-WU LIN; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien; HWEI-FANG TIEN; CHIEN-CHIN LIN |
| 臺大學術典藏 |
2020-10-28T08:35:04Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Lee S.-H.; Lin C.-C.; Wang Y.-H.; Tien H.-F.; CHENG-HONG TSAI; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-04T12:12:14Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Yao M.; Kuo Y.-Y.; Hou H.-A.; Huang T.-C.; Wu S.-J.; Tsai C.-H.; Wang Y.-H.; Lin C.-C.; Lee S.-H.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2020 |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Hou H.-A.; Wu S.-J.; Tsai C.-H.; Lee S.-H.; Lin C.-C.; Wang Y.-H.; Huang T.-C.; Kuo Y.-Y.; MING YAO; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.;Lin C.-C.;Lee S.-H.;Tsai C.-H.;Wu S.-J.;Hou H.-A.;Huang T.-C.;Kuo Y.-Y.;Yao M.;Chang K.;Lin C.-W.;Lin Y.-C.;Tien F.-M.;Wen-Chien Chou;Tang J.-L.;Tien H.-F.; Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; WEN-CHIEN CHOU; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-03-05T09:38:15Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; CHUNG-WU LIN; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T03:42:29Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; LIN YUN-CHU; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:11Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; FENG-MING TIEN; Chou W.-C.; Tang J.-L.; Tien H.-F. |
